InvestorsHub Logo
icon url

Investor2014

11/05/17 8:57 AM

#128676 RE: Turner2017 #128674

More precisely the 109 week data says A2-73 very likely works for certain AD patients, which if it holds true in the P2/3 trial is more than good enough.